|dc.description.abstract||In this thesis I describe a series of studies of the stage at diagnosis and subsequent
survival of women registered with cervical cancer in New Zealand during the period
1994 to 2005, and the factors that may contribute to the demographic differences that
were found in both stage at diagnosis and survival.
The studies involved all of the cervical cancer cases registered on the New Zealand
Cancer Registry between 1994 and 2005. The cases were linked to the National
Mortality Collection (for mortality data), the National Cervical Screening Programme-
Register (for screening history), and the hospital events on the National Minimum
Dataset (for information on comorbid conditions). The studies assessed what
proportions of the ethnic differences in late stage diagnosis (after adjustment for socioeconomic
position) were due to various factors such as screening history and
urban/rural residency, and what proportions of the ethnic differences in survival (after
adjustment for socio-economic position) were due to various factors including stage at
diagnosis, comorbid conditions, and travel time and distance to the nearest General
Practitioner and cancer centre.
Māori and Pacific women had a higher risk of late stage diagnosis compared with
‘Other’ (predominantly European) women. Screening history did not entirely explain
the increased risk in Māori women, but did explain that in Pacific women. More than
half of the women with cervical cancer had not been screened, while those that had been
‘regularly’ screened had a considerably lower risk of a late stage diagnosis. Stage at
diagnosis accounted for some but not all of the ethnic differences in survival.
Comorbidity explained a moderate proportion of the ethnic differences in survival,
while travel time may account for a small proportion of the ethnic differences in stage at
diagnosis, and to a lesser extent mortality, particularly for Pacific women.
The higher risk of late stage diagnosis in Māori women remains largely unexplained,
whereas in Pacific women it is almost entirely due to differences in screening history
and travel time. More than one-half of the higher risk of mortality in Māori and Pacific
women is explained by differences in stage at diagnosis and comorbid conditions.||en_US